Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Nov 11, 2026
TickeronGET DAILY SIGNALS
EFA vs IDEV: Weighing Two iShares Developed-Market ETFs

EFA vs IDEV: Weighing Two iShares Developed-Market ETFs

Key Takeaways

  • EFA tracks the MSCI EAFE Index, covering large- and mid-cap developed markets outside the U.S. and Canada, while IDEV tracks the broader MSCI World ex USA Investable Market Index, which adds Canada and small-cap exposure.
  • IDEV is dramatically cheaper, carrying a 0.04% expense ratio versus EFA's 0.32%, giving it a structural cost advantage over the long term.
  • IDEV is far more diversified, holding roughly 2,200–2,300 securities compared with about 700 for EFA, spreading single-stock and country risk more evenly.
  • Both funds are passively managed, market-cap-weighted international developed-market strategies, but they represent different levels of breadth rather than competing strategies.
  • Tickeron AI Verdict: IDEV is the preferred choice, based on lower cost, broader diversification, and more comprehensive developed-market coverage.

Why These Two ETFs Stand Out in Current Portfolios

International developed-market equities remain a focal point for many investors right now, especially as U.S. valuations look stretched and Europe and Japan offer more attractive relative discounts. The EFA and IDEV ETFs both come from iShares and provide broad exposure to developed markets outside the United States. They are not direct strategy competitors but differ mainly in scope: EFA serves as the established benchmark for Europe, Australasia, and the Far East, while IDEV offers a newer, lower-cost, and more complete version of similar exposure. I checked their relative characteristics using Tickeron’s AI tools to get a clearer picture of how the holdings line up.

A Closer Look at the iShares MSCI EAFE ETF (EFA)

The iShares MSCI EAFE ETF (EFA) aims to track the MSCI EAFE Index, a free-float-adjusted, market-capitalization-weighted benchmark focused on large- and mid-cap equities in developed markets outside the U.S. and Canada. It is passively managed and physically replicated, holding roughly 700 securities across 21 developed countries. The largest country allocations sit in Japan, the United Kingdom, and Switzerland.

Top holdings feature European multinationals such as ASML, AstraZeneca, Novartis, Roche, Shell, HSBC, Nestlé, Siemens, SAP, and Toyota Motor. Sector weights lean toward Financials (roughly 24–25%), Industrials (about 19%), Information Technology (around 11%), and Health Care (about 10%). The fund carries a net expense ratio of 0.32% and benefits from strong liquidity and a long track record.

A Closer Look at the iShares Core MSCI International Developed Markets ETF (IDEV)

The iShares Core MSCI International Developed Markets ETF (IDEV) tracks the MSCI World ex USA Investable Market Index, which covers large-, mid-, and small-cap developed-market equities outside the U.S. Importantly, it includes Canada and reaches further into small caps, unlike EFA.

The fund holds roughly 2,200–2,300 securities, with major country exposures in the Eurozone, Japan, the United Kingdom, and Canada. Top holdings include ASML, AstraZeneca, Novartis, Roche, HSBC, Shell, Nestlé, Royal Bank of Canada, Siemens, and Toyota Motor. Sector allocations are broadly similar but slightly more balanced, led by Financials (about 24%), Industrials (about 19%), Health Care (around 9%), and Information Technology (about 9%). Its standout feature is the net expense ratio of just 0.04%.

Industry and Market Backdrop

Both ETFs operate in the same environment, where international developed markets have gained from a weaker dollar, reasonable valuations, and solid shareholder-return programs in large European and Japanese companies. The significant Financials weighting in each makes them sensitive to interest-rate moves, while Industrials and Materials exposure ties them to global trade and capital-spending cycles. Japan continues to be an important variable, supported by governance reforms and a weak yen for export-oriented firms. Risks include a possible global slowdown, currency swings, geopolitical issues in Europe, and concentration in banks and cyclical sectors. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Performance and Positioning Comparison

Over recent weeks and months the two funds have generally moved together because they share a core of large developed-market holdings. Still, their positioning creates meaningful differences. IDEV’s inclusion of Canada and small caps brings exposure to Canadian financials and energy-linked names that EFA omits. EFA, in turn, carries a slightly heavier tilt toward its largest European positions and shows marginally higher single-name concentration. In recent cycles both have followed the broader shift toward value-oriented international equities, yet IDEV’s lower cost and wider reach have allowed it to compound the underlying exposure more efficiently.

Tickeron AI Verdict

Based on the structural factors outlined above, Tickeron’s AI would likely favor IDEV in this comparison. The fund delivers materially lower costs (0.04% versus 0.32%), broader diversification across roughly three times as many holdings, and more complete developed-market coverage that includes Canada and small caps. These traits generally lead to better risk dispersion and a higher likelihood of efficient long-term compounding. While EFA keeps an advantage in liquidity and familiarity, IDEV’s cost efficiency, diversification profile, and consistent exposure make it the stronger structural option for broad international developed-market positioning.

Using Tickeron’s AI Screener for ETF Research

In my own analysis, I frequently rely on Tickeron’s AI Screener to compare ETF characteristics side by side. It lets me quickly filter by holdings overlap, expense ratios, and sector exposures, which helps confirm that the cost and diversification edge sits with IDEV while still showing where EFA’s liquidity profile may matter for certain strategies. This kind of data-driven check keeps the decision process grounded in observable metrics rather than assumptions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EFA, IDEV

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


EFA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for EFA turned positive on October 15, 2026. Looking at past instances where EFA's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EFA as a result. In 64 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFA advanced for three days, in 260 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 60 cases where EFA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.

EFA moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

EFA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EFA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Spotify Technology SA (NYSE:SPOT), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Nokia Corp (NYSE:NOK), Nebius Group N.V. (NASDAQ:NBIS).

Industry description

The investment seeks to track the investment results of the MSCI EAFE Index composed of large- and mid-capitalization developed market equities, excluding the U.S. and Canada. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted, market capitalization-weighted index designed to measure large- and mid-capitalization equity market performance of developed markets outside of the U.S. and Canada.

Market Cap

The average market capitalization across the iShares MSCI EAFE ETF (EFA) ETF is 47.28B. The market cap for tickers in the group ranges from 439.99M to 123.97B. SPOT holds the highest valuation in this group at 123.97B. The lowest valued company is HKD at 439.99M.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI EAFE ETF (EFA) ETF was 1%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 2%. TIGO experienced the highest price growth at 15%, while USD experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI EAFE ETF (EFA) ETF was 2%. For the same stocks of the ETF, the average monthly volume growth was 30% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 54
Price Growth Rating: 50
SMR Rating: 60
Profit Risk Rating: 59
Seasonality Score: 9 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
The central target of $1,620 is the arithmetic mean of verified, current analyst price targets, rounded to a clean level; it is not a single firm's forecast or a guarantee. At a recent price of about $690 , reaching $1,620 would require a gain of roughly 135% , a very large move by any standard.
The $1.50 central target is a fallback objective drawn from public market and technical discussion, not an analyst consensus, because AquaBounty Technologies, Inc. (NASDAQ: AQB) has no credible, current sell-side price targets. With the stock near $0.95, reaching $1.50 would require roughly 58% upside, a very large move for a company that has wound down its core aquaculture operations.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.